News in the classification of WHO 2022 bladder tumors.
Raspollini MR, Comperat EM, Lopez-Beltran A, Montironi R, Cimadamore A, Tsuzuki T, Netto GJ.
Pathologica. 2022 Feb;115(1):32-40. doi: 10.32074/1591-951X-838. Epub 2023 Jan 25.
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, Palou J, Peyronnet B, Seisen T, Soukup V, Sylvester RJ, Rhijn BWGV, Zigeuner R, Shariat SF.
Eur Urol. 2021 Jan;79(1):62-79. doi: 10.1016/j.eururo.2020.05.042. Epub 2020 Jun 24.
Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
Caramelo B, Zagorac S, Corral S, Marqués M, Real FX.
Eur Urol Oncol. 2023 Aug;6(4):366-375. doi: 10.1016/j.euo.2023.02.011. Epub 2023 Mar 6.
Non-urothelial carcinomas of the bladder.
Park S, Reuter VE, Hansel DE.
Histopathology. 2019 Jan;74(1):97-111. doi: 10.1111/his.13719.
Disappearance of Upper Urinary Tract Urothelial Carcinoma after Treatment of a Borderline Brenner Tumor: Case Report and Literature Review.
Aoun F, Kourie HR, Sirtaine N, Hawaux E.
Oncol Res Treat. 2015;38(7-8):379-81. doi: 10.1159/000433488. Epub 2015 Jun 18.
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives.
Tonni E, Oltrecolli M, Pirola M, Tchawa C, Roccabruna S, D'Agostino E, Matranga R, Piombino C, Pipitone S, Baldessari C, Bacchelli F, Dominici M, Sabbatini R, Vitale MG.
Int J Mol Sci. 2024 Sep 7;25(17):9696. doi: 10.3390/ijms25179696.
Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma.
Jin X, Wang Q, Luo F, Pan J, Lu T, Zhao Y, Zhang X, Xiang E, Zhou C, Huang B, Lu G, Chen P, Shao Y.
Chin Med J (Engl). 2023 Mar 20;136(6):690-706. doi: 10.1097/CM9.0000000000002573.
Ureteral tumor with morphological features analogous to phyllodes tumor: a unique case with concomitant urothelial carcinoma.
Zhou W, Dang L, Chong C, Cheng X, Qin Y, Su W.
Diagn Pathol. 2022 Dec 23;17(1):94. doi: 10.1186/s13000-022-01277-6.
Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
Paver EC, Cooper WA, Colebatch AJ, Ferguson PM, Hill SK, Lum T, Shin JS, O'Toole S, Anderson L, Scolyer RA, Gupta R.
Pathology. 2021 Feb;53(2):141-156. doi: 10.1016/j.pathol.2020.10.007. Epub 2020 Dec 30.
[Tumour-stroma interactions in urothelial cancer].
Hatina J, Kripnerová M, Tuková J, Šrámek J, Dvořák P, Pešta M, Dobrá J, Babuška V, Racek J, Sobol M, Philimonenko A, Hozák P, Czuba Z, Schulz WA, Strell C, Grimm S, Jennek S, Friedrich KH.
Urologe A. 2015 Apr;54(4):516-25. doi: 10.1007/s00120-014-3754-3.
